Zurich, Switzerland, September 3–8, 1989
eBook - PDF

Zurich, Switzerland, September 3–8, 1989

  1. 1,376 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Zurich, Switzerland, September 3–8, 1989

Book details
Table of contents
Citations

About This Book

No detailed description available for "Zurich, Switzerland, September 3–8, 1989".

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Zurich, Switzerland, September 3–8, 1989 by Hans-Christoph Curtius,Sandro Ghisla,Nenad Blau in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Science General. We have over one million books available in our catalogue for you to explore.

Information

Publisher
De Gruyter
Year
2019
ISBN
9783110889000
Edition
1

Table of contents

  1. Preface
  2. Adrien Albert
  3. Alois Niederwieser
  4. Tetsuo Shiota
  5. Contents
  6. I CHEMISTRY OF PTERINS AND FOLATES
  7. Recent progress in pteridine chemistry
  8. Synthesis of pteridines for immunoassay of biopterin and neopterin isomers
  9. Design of new mechanism-based substrates for dihydrofolate reductase
  10. New methods for the synthesis of quinazoline antifolates and poly-y-glutamyl metabolites of folates and antifolates
  11. The decay of quinoid- and 7,8-dihydropterins
  12. Synthesis of 6-acetyl-2,4-diamino-7,8-dihydro-9//-pyrimido-[4,5-b][l,4]- diazepine, an amino analog of 6-acetyldihydrohomopterin
  13. Synthetic approaches to methanopterin
  14. Synthesis and properties of tetrahydropterins coupled to 1,4-dihydropyridines
  15. A new synthesis of biopterin and some analogues from epoxyaldehydes
  16. Synthetic studies on the molybdenum cofactor
  17. A new regiospecific synthesis of anapterin and primapterin
  18. A novel and efficient synthesis of folylpolyglutamates
  19. Reaction of acidic anhydride and pyridine with folic acid and classical antifolates
  20. Quinazoline antifolate thymidylate synthase inhibitors: Synthesis of analogues containing heterocyclic isosteres of the para-aminobenzoate unit
  21. Synthesis of tetrahydro-8-deazabiopterin
  22. Synthesis and enzymic properties of new mechanism based substrates for dihydrofolate reductase of the 8-substituted pterin class.
  23. Imidazolines as carbon-transfer vehicles: models of the tetrahydrofolate (and other) coenzymes
  24. Asymmetric synthesis and absolute configuration of 5,10-dideaza- 5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid
  25. Synthesis and biological evaluation of a fluorescent analogue of folic acid
  26. Metal complexes of tetrahydroneopterin
  27. Syntheses of lipophilic analogues of 2-desamino-2-CH3-NIO-propargyl- 5,8-dideazafolate targeted at the enzyme thymidylate synthase (TS).
  28. Studies in models of folate cofactors: oxidation of 5-methyltetrahydropterin revisited.
  29. New strategy in the synthesis of neopterin phosphates
  30. First regiospecific synthesis of 7-iso-D-neopterin and 7-iso-D-neopterin- 3 '-monophosphate
  31. II. ANALYSIS OF PTERINS AND FOLATES
  32. Detection of pterins in biological material using mass spectrometry
  33. Mass spectrometric methods for the structural determination of pteridines and folic acid derivatives
  34. Structural characterization of underivatized pteridines by laser desorption fourier transform mass spectrometry
  35. New immunoassays for determination of biopterin and neopterin in body fluids
  36. A new immunoassay for neopterin and biopterin
  37. Enzyme immunoassay for urinary neopterin
  38. A competitive enzyme linked ligand sorbent assay (ELLSA) for quantitation of erythrocyte folates
  39. Preparation of a bovine serum albumin based chiral matrix for resolution of (6R,S)-N<sup>5</sup>-formyltetrahydrofolate.
  40. Rp-HPLC methods for the isolation and chemical identification of pterins from monocytic blood cells
  41. Cyclodextrin based HPLC separation of 6-S and 6-R diastereomers of 5,10-dideaza and 5-deazatetrahydrofolates.
  42. Analysis of folate and antifolate metabolites by mass spectrometry
  43. A critical assessment of methods for measuring folate in human serum and red blood cells.
  44. HPLC analysis of intracellular folate compounds after enzymic conversion to the corresponding pteroates
  45. III. BIOSYNTHESIS AND BIOCHEMISTRY OF PTERINS
  46. The Gowland Hopkins Lecture: Biosynthesis of H<sub>4</sub>biopterin and related compounds
  47. The structure of<sub>q</sub>-Bh<sub>2</sub> - chemistry and biochemistry
  48. Pteridines in riboflavin biosynthesis
  49. Pteridine mimicking antibodies
  50. 6-Pyruvoyl-tetrahydropterin reductases
  51. Analysis of 6-pyruvoyl tetrahydropterin synthase, a target gene product of su(s) suppressor in Drosophila
  52. Synthesis of fluorinated 8-ribityllumazines as "F NMR probes and potential inhibitors of the light riboflavin synthase of Bacillus subtilis
  53. Studies on the oxidation state and biosynthesis of molybdopterin
  54. Molybdenum cofactor genes in Drosophila
  55. DNA photolyase: role of pterin in DNA repair.
  56. 7-Substituted pterins, a new class of mammalian pteridines
  57. Methanopterin: A structural and functional folic acid analogon in the biochemistry of methanogenic bacteria.
  58. Biosynthesis of methanopterin
  59. Tetrahydrobiopterin is required for the oxidation of arginine to nitric oxide by macrophages.
  60. Biosynthesis of 7-hydroxybiopterin
  61. GTP cyclohydrolase I from Escherichia coli. Molecular cloning and crystallization
  62. Molecular characterization of the GTP cyclohydrolase I gene of Drosophila: analysis of cDNA clones
  63. Inhibitors of bovine adrenal medullary sepiapterin reductase
  64. Catalytic implication of the reductase and isomerase activity of sepiapterin reductase in the biosynthesis of tetrahydrobiopterin
  65. Purification and characterization of sepiapterin reductase from human liver
  66. Biosynthesis of methanopterin and deazaflavin in Methanobacterium thermoautotrophicum
  67. Studies on riboflavin synthases of Bacillus subtilis. Amino acid sequence of the a subunit
  68. Structure of the lumazine synthase/riboflavin synthase complex of Bacillus subtilis: crystallization of hollow reconstitutß<sub>60</sub>, capsids.
  69. Biosynthesis of 6,7-dimethyl-8-ribityllumazine. Purification and properties of 3,4-dihydroxy-2-butanone 4-phosphate synthase
  70. High resolution electron microscopy on crystals of the icosahedral lumazine synthase/riboflavin synthase complex.
  71. Differential synthesis of LDH A-like proteins and of phosphoproteins in response to the modified deazaguanine-derivative queuine
  72. Metabolic control in HeLa-cells mediated by the deazaguanine-derivative queuine
  73. On the biosynthesis of the deazaguanine-derivative queuine: structure of the tgt gene of E. coli
  74. Changes in the level of biopterin and of queuine-containing tRNA during erythroid differentiation of murine erythroleukemia cells
  75. Brain contents of biopterins and monoamines after intraperitoneal injections of SUN0588, active 6R-tetrahydrobiopterin, during ontogeny in rats
  76. The effect of 2,4-diamino-6-hydroxypyrimidine on tetrahydrobiopterin and serotonin in the gastrointestinal tract of mice.
  77. Differential metabolism of tetrahydrobiopterin in central and peripheral monoamine neurons maintained in culture
  78. IV. TETRAHYDROBIOPTERIN DEFICIENCY
  79. Inborn errors in tetrahydrobiopterin metabolism
  80. Molecular defects in dihydropteridine reductase deficiency
  81. Screening and treatment of tetrahydrobiopterin deficiency
  82. Tetrahydrobiopterin deficient phenylketonuria detected by neonatal screening in Taiwan
  83. Prenatal diagnosis of 6-pyruvoyl tetrahydropterin synthase deficiency in East Asia.
  84. Heterogeneity of tetrahydrobiopterin deficiency: combined phenylalaninetetrahydrobiopterin loading test
  85. Unusual case of atypical PKU: peripheral or central form of PPH4S deficiency
  86. Development of vision in BH<sub>4</sub>, deficiency
  87. Fetal guinea-pig model of tetrahydrobiopterin deficiency
  88. Unexpected favorable clinical results of therapy in late diagnosed DHPR deficiency
  89. Systematic investigation for biopterin defects in hyperphenylalaninemic patients
  90. Neuroradiological improvement after one year of therapy in a case of DHPR deficiency
  91. V. PTERINS VARIOUS
  92. Lumazine protein and the bioluminescence of photobacterium
  93. Binding of pteridine derivatives to lumazine apoprotein
  94. Hormonal imbalance by pteridine treatment in diapausing Pieridae induces mutations in the progeny of treated Drosophila melanogaster
  95. N-acetyltransferase activity in Pieris brassicae
  96. VI. BIOLOGY OF PTERINS
  97. Pteridines and the immune response.
  98. Neopterin elevation and interferon induction in viral diseases
  99. Tetrahydrobiopterin in human T cells: control of its biosynthesis by interferon-y and interleukin 2 - modulator function in interleukin 2 perception
  100. Effects of BH<sub>4</sub> on the synthesis of serotonin in brain slices and synaptosomes: implications for the use of BH<sub>4</sub> as a therapeutic agent
  101. Regulation of cellular proliferation by tetrahydrobiopterin
  102. Characterisation of the mutation in dihydropteridine reductase deficiency
  103. Urinary excretion of total pteridines in cancer
  104. Alterations of interferon-gamma-induced monocyte activation by immunomodulating compounds determined by neopterin production
  105. Levels of neopterin, biopterin, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid of sick neonates and infants
  106. Urinary neopterin levels in healthy children
  107. Urinary neopterin factor in viral and bacteriological children infections
  108. Urinary neopterin levels in liver transplant
  109. The effect of IL-2, neopterin and immunomodulators on neopterin release from macrophages and PBMC
  110. Membrane transport of unconjugated pteridines. The model of human erythrocytes.
  111. Encephalopathy and abnormal cerebrospinal fluid pteridine profile. Fact or artefact ?
  112. Informativity of pteridine measurements in the survey of organ transplantations
  113. Effect of triamteren on urinary excretion of pterins in different rat strains
  114. Pteridines and retinal degenerations in rats and humans
  115. Pterins in bovine, rat, quail and human retina
  116. Comparison of urinary biopterin in rats with various housing and enviromental conditions
  117. Differences in the quantity and distribution of urinary pterins in various species of mammals
  118. Total biopterin levels in the ventricular CSF of Parkinson's disease and essential tremor
  119. Urinary xanthopterin and derivatives as indicators of liver disease
  120. Genetic control of dihydropterin oxidase activity in Drosophila melanogaster
  121. A controlled system for supplementation experiments in Drosophila melanogaster
  122. New eye-color mutants affecting the biosynthesis of pteridines and ommochromes in Drosophila melanogaster
  123. Search for 6- and 7-biopterins in human saliva
  124. VII. TETRAHYDROBIOPTERIN-DEPENDENT MONOOXYGENASES
  125. Regulation of the aromatic amino acid hydroxylases
  126. Expression of rat liver dihydropteridine reductase in Escherichia coli
  127. Escherichia coli dihydropteridine reductase is a trifunctional enzyme with dihydrofolate reductase activity.
  128. Rat liver preparations with glyceryl etherase activity
  129. Purification and characterization of a membrane associated folate binding protein from human leukemic CCRF-CEM cells
  130. On the effects of high protein diet and of starvation on phenylalanine hydroxylase activities in rats.
  131. Effects of experimental diabetes on phenylalanine hydroxylase activities in rats
  132. Molecular defects of PKU in Italy differ from those of other European countries
  133. The oxidation of tetrahydropteridines by phenylalanine hydroxylase
  134. Interaction of catecholamines and tetrahydropterins with bovine liver phenylalanine hydroxylase
  135. Studies of tetrahydrobiopterin uptake in rat brain synaptosomes
  136. The influence of cofactor side-chain chirality on the activity and regulation of phenylalanine and tyrosine and hydroxylases
  137. Limited denaturation stimulates tetrahydrobiopterin-dependent activity of rat liver phenylalanine hydroxylase
  138. Effect of limited proteolysis on structure and activity of phenylalanine hydroxylase
  139. Tetrahydropterin as a possible natural cofactor in the Drosophila phenylalanine hydroxylation system
  140. Interaction of substrate analog inhibitors with rat liver dihydropteridine reductase
  141. Simultaneous purification of phenylalanine hydroxylase, phenylalanine hydroxylase stimulator protein, and dihydropteridine reductase from rat liver
  142. A. DIHYDROFOLATE REDUCTASE
  143. NMR and mutagenesis studies of dihydrofolate reductase
  144. Spectroscopic studies of the interaction of ligands with dihydrofolate reductase
  145. Comparison between human and bacterial dihydrofolate reductase structures
  146. Mutagenesis of human dihydrofolate reductase structure as a probe of enzyme function
  147. Folate and dihydrofolate reduction by mouse dihydrofolate reductase
  148. Kinetic mechanism of recombinant human dihydrofolate reductase
  149. The kinetic mechanism of the reaction catalyzed by an R-plasmid (R-67) dihydrofolate reductase from E.coli.
  150. Mechanism based inhibitors of dihydrofolate reductase.
  151. Trimetrexate resistant L. casei and S. faecium
  152. Second site revertants of E. coli dihydrofolate reductase
  153. Structural and energetic aspects of the reaction pathway and transition state for hydride-ion transfer in dihydrofolate reductase
  154. Cloning of trimethoprim-resistant dihydrofolate reductase from multiresistant staphylococci and expression in E. coli
  155. Role of TRP-24 in binding and catalysis for human dihydrofolate reductase (DHFR)
  156. Mutation at hydrophobic residues in dihydrofolate reductase
  157. Determination of the functional role of phenylalanine-31 of recombinant human dihydrofolate reductase by site-directed mutagenesis
  158. Molecular modeling studies and crystal structure determination of pteridine antifolate-DHFR enzyme interactions
  159. Allelic variants of Chinese hamster dihydrofolate reductase
  160. B: THYMIDYLATE SYNTHASE
  161. Thymidylate synthase - structural and functional considerations
  162. Defining the catalytic role of specific amino acids in thymidylate synthase by site-specific mutagenesis
  163. Studies of the effects of mutagenesis on a conserved active site arginine residue in thymidylate synthase
  164. Dual role of serine hydroxymethyltransferase in the synergy of fluorouracil and leucovorin: effects of L-serine and glycine on H<sub>4</sub>PteGlu/5,10-CH<sub>2</sub>-H<sub>4</sub>PteGlu ratios; and H<sub>4</sub>PteGlu-catalyzed release of fluoride ion from alpha-fluoro-beta alanine.
  165. Interaction of N<sup>4</sup>-hydroxy-dCMP and N<sup>4</sup>-hydroxy-5-FdCMP with L1210 thymidylate synthase differing in sensitivity towards 5- FdUMP Inhibition
  166. Mechanism of thymidylate synthase inhibition by N<sup>4</sup>-Hydroxy-dCMP
  167. Thymidylate synthase activity in bronchoalveolar lavage cells as a possible marker in lung cancer diagnosis
  168. Purification and properties of Hymenolepis diminuta and regenerating rat liver thymidylate synthases
  169. Influence of FdUMP on the binding of methotrexate to thymidylate synthase
  170. Efficient expression of mammalian thymidylate synthase in Escherichia coli
  171. Catalytic role of histidine-147 in Escherichia coli thymidylate synthase
  172. Variation among human thymidylate synthase enzymes in folate affinity
  173. Evaluation of in vivo inhibition of thymidylate synthase in patients with colorectal cancer treated with 5-fluorouracil
  174. Effect of leucovorin on 5-fluorouracil induced inhibition of thymidylate synthase in murine colon cancer
  175. Feedback inhibition of thymidylate synthase by dihydrofolate polyglutamates cannot account for partial depletion of tetrahydrofolate cofactors by antifolates
  176. Kinetic studies on thymidylate synthase from Lactobacillus casei
  177. C. METHIONINE SYNTHASE
  178. Studies on the cobalamin-dependent methionine synthase from Escherichia coli K12
  179. Foimyl phosphate as an intermediate in the N<sup>10</sup>-formyltetrahydrofolate synthetase reaction.
  180. Enzymes of homocysteine remethylation and transsulfuration in methionine or cholesterol induced atherosclerosis in rabbits
  181. Biochemical changes in porcine neural tissue after inactivation of methionine synthase by nitrous oxide.
  182. Increased synthesis of AdoMet but not of methionine during testosterone stimulation of polyamine biosynthesis in mouse kidney
  183. D. ENZYMOLOGY AND METABOLISM
  184. Role of folylpolyglutamate synthetase in the regulation of folate and antifolate metabolism.
  185. NAD-dependent methylenetetrahydrofolate dehydrogenase-cyclohydrolase present in transformed mammalian cells
  186. Gammaglutamyl hydrolases
  187. Human methenyltetrahydrofolate synthetase
  188. Folate catabolism in man and the rat
  189. Effects of growth rate on y-glutamyl hydrolase in Ehrlich ascites carcinoma cells
  190. Folylpolyglutamate synthesis in Neurospora crassa. Wild type FPGS activity and transformation of polyglutamate deficient mutants using cosmid vectors containing the met-6 gene
  191. Cloning and expression of the gene encoding Lactobacillus casei folylpolyglutamate synthetase in Escherichia coli
  192. Effect of treatments with different anticonvulsant drugs on folate pattern in rat liver.
  193. A sensitive new microassay useful for measurement and purification of mammalian folylpolyglutamate synthetase
  194. Tissue differences in N<sup>5</sup> formyltetrahydrofolate metabolism
  195. E. FOLATES IN ENDOGENOUS PURINE METABOLISM
  196. Glycinamide ribonucleotide transformylase from E. coli: characterization and inhibition.
  197. Estimation of the flux control coefficient of glycineamide ribonucleotide transformylase for purine biosynthesis de novo
  198. Monocyclic 5-deazatetrahydrofolate analogues as inhibitors of de novo purine biosynthesis
  199. Inhibition of glycinamide ribonucleotide transformylase, methotrexate transport, and the growth of MCF-7 cells by 5,8-dideazafolates
  200. F. FOLATES, VARIOUS
  201. Formation of methylcobamide from methyltetrahydrofolate by acetogenic bacteria: enzymology and redox chemistry.
  202. Incorporation of the ring carbon of histidine into coenzymes of folylpolyglutamates.
  203. In vivo effect of folic acid on fragile-site expression
  204. IX. ANTIFOLATES
  205. A. DEAZADERIVATIVES
  206. New synthetic studies on deazafolates
  207. Molecular modeling studies on deazatetrahydrofolates
  208. Biochemical pharmacology of deazatetrahydrofolates
  209. Synthesis and evaluation of l-deaza-7,8-dihydropteridines and ring analogues
  210. In vitro and in vivo activity of the GAR transformylase inhibitor 5-deazacyclotetrahydrofolate
  211. vitro and in vivo studies with 2-desamino-2-CH<sub>3</sub>-N<sup>10</sup>-propargyl-5,8- dideazafolate (ICI 198583), an inhibitor of thymidylate synthase
  212. Comparative studies on the activity of methotrexate and the analog 10-ethyl-10-deaza-aminopterin (10-EdAM) against head and neck carcinoma cell lines and xenografts.
  213. Transport of 5,10-dideazatetrahydrofolic acid (DDATHF) in CCRF-CEM sensitive and methotrexate resistant cell lines
  214. Synthesis and structure-activity relationship studies of 5,10- dideazatetrahydrofolic acid (DDATHF)
  215. Synthesis and antifolate properties of 5-alkyl-5-deazaaminopterin analogues modified in the 10-position
  216. Synthesis and biological evaluation of 2-desamino-2-methyl-5,10- dideazatetrahydrofolate
  217. Quinazoline antifolate thymidylate synthase inhibitors: potent cytotoxic agents containing heterocyclic isosteres of the para-amino benzoate unit
  218. Antifungal activity of some 2,4-diamino-5-methyl-6-alkyl quinazoline
  219. Membrane transport characteristics of the thymidylate synthase inhibitor 2-desamino-2-methyl-N<sup>10</sup>-propargyl-5,8-dideazafolic acid.
  220. Synthesis and potential antitumor activity of 5-deaza analogs of 5,10- methylenetetrahydrofolic acid
  221. Theoretical studies of the structures and conformations of triazine antifolates
  222. In vitro and in vivo metabolism of 5-DACTHF, an acyclic tetrahydrofolate analog
  223. Measurement of retained thymidylate synthase (TS) inhibition by antifolates in whole cells in vitro
  224. Substitution on the benzene ring of quinazoline antifolates that inhibit thymidylate synthase
  225. Inhibition of de novo purine synthesis by deazatetrahydrofolates
  226. B.Methotrexates
  227. Resistance to methotrexate in experimental models and in patients
  228. Methotrexate peptides as cancer chemotherapeutic agents
  229. Biochemical determinants of methotrexate selectivity
  230. Mechanisms underlying methotrexate inactivity in human head and neck cancer xenografts
  231. Design and synthesis of novel methotrexate derivatives for antibody directed drug targeting
  232. Methotrexate (MTX) transport and cytotoxity of MTX and trimetrexate (TMQ) for human squamous cell carcinoma (SCC) of the head and neck grown at low folate concentrations
  233. Folate enhancement of antifolate synergism in lymphoma cells
  234. Amino acid oxidation and dihydrofolate reductase inactivation photosensitized by a diaminopteridine
  235. Synchronisation of U937 and SW626 cancer cell lines of human origin using methotrexate
  236. New inhibitors of plasmodial folate synthesis - comparison of cell-free, whole cell and in vivo activities for single drugs and drug combinations
  237. Effect of vincristine on methotrexate cytotoxicity and accumulation in MCF-7 cells, a human breast cancer cell line
  238. The y-tetrazole analog of methotrexate: design, synthesis and biological activity
  239. Effect of intravenous 24 hr infusions of methotrexate on unconjugated pteridine metabolism
  240. Covalent labeling of dihydrofolate reductase and folate transport proteins by fluorescein methotrexate
  241. Study of methotrexate polyglutamate formation in cultured leukemic cells
  242. C. Various Antifolates
  243. Folyl polyglutamates in metabolism and chemotherapy
  244. Biological determination of selective antitumor action of 4-amino-folate analogs
  245. Inhibition of the thymidylate synthase cycle of leukemia cells by antifolates: The usefulness of the cellular tritium release assay
  246. Fluoroglutamate-containing folates and antifols: probing the role of polyglutamylation in vitro
  247. Therapeutic strategies for 5-fluorouracil-leucovorin based upon cellular metabolic characteristics in human colon adenocarcinoma xenografts
  248. The lack of response of human colonic tumor cell lines to biochemical modulation by folinic acid.
  249. Folinic acid as a source of intracellular 5,10-methylenetetrahydrofolate in human carcinoma cells
  250. Structure activity relationships of multidrug resistance
  251. Enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cell lines by leucovorin
  252. D. Transport And Absorption Of Folates And Antifolates
  253. Methotrexate transport via the high-affinity folate binding protein of L1210 cells.
  254. Combined affinity and ion pair liquid chromatographies for direct analysis of tissue folate composition
  255. Tumor cell sensitivity and resistance to folate analogues: the role of carrierand receptor-mediated transport systems
  256. Lysosomal permeability to methotrexate polyglutamates
  257. Folic acid metabolism in placental cells associated with neural tube defects
  258. Homologous membrane folate binding proteins in human placenta
  259. A high-affinity folate binding protein in human amniotic fluid
  260. Interaction of N-hydroxy(sulfo)succinimide active esters with the reduced folate/methotrexate transport system from human CCRF-CEM leukemia cells
  261. Renal uptake and metabolism of 5-methyltetrahydrofolate in the rat
  262. Methotrexate- and folate-lipid conjugates of defined chemical structures as new antifolate analogs and transport probes
  263. Characterization of receptor-mediated (anti)folate uptake in human CCRF-CEM cells
  264. Author Index
  265. Subject Index
  266. List of Participants